Preclinical studies suggest that retatrutide might influence being overweight-associated most cancers progression. Inside a research led by Marathe et al., retatrutide-induced weight reduction diminished tumor engraftment, delayed tumor onset, and appreciably attenuated tumor expansion in pancreatic and lung cancer designs, with greater tumor suppr